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Abstract: Identification of factors that determine length of stay (LOS) in total anterior circulatory
stroke (TACS) has potential for targeted intervention to reduce the associated health care burden.
This study aimed to determine which factors predict LOS following either ischaemic or haemorrhagic
TACS. The study sample population was drawn from the Norfolk and Norwich Stroke and Transient
Ischemic Attack (TIA) Register (1996–2012), a prospective registry. 2965 patients admitted with
TACS verified by a stroke specialist team were included. Primary analysis identified predictors
of length of stay (LOS) in either haemorrhagic or ischaemic TACS. Secondary analyses identified
predictors of LOS in patients who were discharged alive or who died during admission separately.
Moderate (p = 0.014) to severe disability (p = 0.015) and history of congestive heart failure (p = 0.027)
in the primary analysis and pre-stroke residence in a care facility among patients who survived to
discharge (p = 0.013) were associated with a shorter length of stay. Factors associated with increased
length of stay included presence of neurological lateralisation in the primary analysis (p = 0.004)
and amongst patients who died (p = 0.003 and p = 0.014 for ischaemic and haemorrhagic stroke,
respectively). Patients with advanced age (≥85 years) with haemorrhagic stroke had longer LOS
regardless of mortality outcome. Patients with low pre-morbid disability (modified Rankin score ≤2
who died following haemorrhagic TACS also had longer LOS. Our study found predictors of LOS
following TACS include neurological lateralisation, pre-stroke disability status, congestive heart
failure, pre-morbid residence and age. The identification of such factors would assist in resource
allocation and discharge planning.
Keywords: haemorrhagic stroke; ischaemic stroke; length of stay; mortality; total anterior
circulatory stroke
1. Introduction
Stroke is a leading cause of death and disability worldwide with an annual incidence of 152,000 per
year in the UK [1] and 795,000 in the United States [2]. The cost of providing acute and long-term care,
along with estimated loss of productivity costs in stroke patients, is over 8 billion pounds per year [3]
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in the UK. Annual costs in the United States reach 33.6 billion dollars, of which 7.6 billion dollars are
attributed directly to inpatient stays [2] representing a major economic burden to the health services.
Length of stay (LOS) in acute medical care is a significant contributor to the financial implication of
caring for stroke patients and the ability to accurately predict which patients are likely to require longer
inpatient care would be desirable for both budgetary planning and healthcare provider considerations,
and also in communicating with patients and families to manage expectations at a vulnerable and
uncertain time [4].
Total anterior circulation stroke (TACS), as defined by the Oxford Community Stroke Project
classification [5], constitutes around 17% of stroke [5] and is a severe form of stroke associated with
higher mortality rates [6], higher healthcare costs [7] and longer length of stay [8] than other stroke
subtypes. Deeper insight and better understanding of factors that determine LOS in TACS creates the
potential for targeted intervention to reduce the associated health care burden.
We [9,10] and others [11] have derived and validated clinical prediction tools to predict length
of stay in acute stroke, but mostly in cohorts of stroke patients with varying severity. We recently
identified major determinants of mortality in TACS and derived a novel scoring system, the TACS-6
score, to predict mortality [12]. However, there is no tool in current clinical use that has been derived
to specifically predict length of stay following this most severe form of stroke. The purpose of this
study was to identify what factors in TACS patients were associated with hospital length of stay.
2. Methods
The study participants were drawn from the Norfolk and Norwich Stroke and Transient Ischemic
Attack (TIA) Prospective Register that has routinely collected data from its inception (Nov 1996) at the
Norfolk and Norwich University Hospital. The patients included in the study were admitted between
1996 and 2012. The hospital is a regional tertiary care hospital with a catchment population of ~750,000,
which provides a comprehensive stroke care service including a hyper acute stroke unit, a step-down
acute stroke unit and multi-disciplinary medical and rehabilitation care. Data collection methods were
previously reported [13,14].
For the purposes of this study, patients diagnosed with a TACS and entered into the registry for
the first time were included. TACS was defined as a significant ischemic or hemorrhagic event affecting
the middle and/or anterior cerebral artery territories. Clinically, a diagnosis of TACS was made by the
presence of all three of the following: unilateral weakness (and/or sensory impairment) of face, arm
and leg, homonymous hemianopia and higher cortical dysfunction (dysphasia and/or visuospatial
disorder). If lateralisation (i.e., unilateral weakness) was absent, the diagnosis was made radiologically,
such as by arterial territory involved and degree of the neurological deficit in conjunction with other
clinical signs (e.g., eye deviation/obvious neglect). Computed tomography (CT) was the first line
imaging modality, with Magnetic Resonance Imaging (MRI) performed in CT negative cases. Not all
ischaemic stroke underwent CT angiography in addition to non-contrast CT.
Variables of interest included age, sex, stroke sub-type (ischemic or hemorrhagic), pre-stroke
functional status as a marker of frailty assessed using the pre-stroke modified Rankin score
(mRs 0 = no symptoms, mRs 5 = severe disability, completely dependent on care) and pre-stroke
residence. Patients with modified rankin scores 4 and 5 (moderately severe and severe disability)
were combined for the analysis as these represented collectively a vulnerable group. We considered
sheltered housing as a pre-care home state (N = 8) and mental health facility (N = 2) as a care setting.
Comorbidities were retrieved from electronic discharge letters on the patient administration system.
Comorbidities (including atrial fibrillation (AF), diabetes mellitus, myocardial infarction (MI), chronic
kidney disease, and congestive heart failure) that could influence LOS were included. Comorbidities
with less than 5 patients recorded were excluded from the analyses as comparisons with these groups
would not be statistically useful. Length of stay was considered as the period in days from date of
admission to date of discharge from the hospital for those who survived or from date of admission to
date of death for those patients who died as an inpatient.
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Descriptive statistics for each potential explanatory factor was given as the number and percentage
in each category. A linear regression model was used to identify the association between potential
explanatory factors and length of stay. When there was less than 5 events the category it was excluded
from the model. The assumptions standard regression analysis was not met as the residuals were
not normally distributed, hence a non-parametric bootstrap was used to estimate the p-values and
confidence intervals. 1000 iterations of the bootstrap were used. Statistical significance was considered
as p ≤ 0.05. Statistical analysis was performed using Stata 14 (StataCorp, College Station, TX, USA).
Ethical approval was obtained from the Newcastle and Tyneside National Health Service (NHS)
Research Ethics Committee (12/NE/0170) and the study protocol was approved by the Steering
Committee of the Register.
Given the inherent differences in management and prognosis, the analyses were conducted
for ischemic and hemorrhagic stroke specifically in the whole sample. Subgroup analysis was then
performed to examine the factors associated with length of stay separately for patients who survived
to discharge and those who died as inpatients in line with our previous work [15].
3. Results
A total of 2965 patients with total anterior circulation stroke (42.0% male, mean age 76.9± 10.8 years,
58.0% female, mean age 81.5 ± 9.3 years) were included in the current study. The median age of the
whole sample was 81 years (range = 20–102 years; IQR 74–86 years). There were 232 (7.8%) aged less
than 65 years, 1717 (57.9%) aged 65–84 years and 1016 (34.3%) aged 85 years or more. 2439 (82.2%) had
an ischemic stroke. 526 (17.7%) had a haemorrhagic stroke. 2693 (90.8%) patients were admitted with
clinical features consistent with lateralisation of neurological deficit. 456 (15.4%) patients were admitted
from a care home. 1477 (58.7%) were fully independent prior to admission with baseline modified
Rankin scores of 0. Data for modified Rankin scores was available for 2517 out of 2965 patients.
486 (16.4%) had atrial fibrillation, 290 (9.8%) had congestive heart failure, 54 (1.8%) had chronic kidney
disease, 150 (5.1%) had a previous myocardial infarction and 88 (3%) were diabetic. 1707 patients
(57.6%) died during their admission, of whom 1379 (46.5%) patients had an ischaemic TACS and
328 (11.1%) patients had a haemorrhagic TACS. Table 1 shows the sample characteristics.
Table 2 details the length of stay analysis separately for the ischemic and hemorrhagic stroke
subtypes. In the ischemic stroke group, moderate (mean LOS 16 days, p = 0.014) and moderately
severe or severe disability (mean LOS 15 days, p = 0.015) prior to TACS (modified Rankin score 3 and 4
or 5) were both significantly associated with shorter length of stay as compared with those who had
no baseline disability (modified Rankin score 0). In the haemorrhagic stroke group, the presence of
lateralisation (mean LOS 16 days, p = 0.004) was associated with a longer length of stay and those
patients with a history of congestive heart failure (mean LOS 5 days, p = 0.027) had significantly shorter
length of stay.
Tables 3 and 4 show the stroke subtype specific length of stay results for the patients who were
alive at discharge or who died as inpatients respectively. In patients who survived an ischemic TACS,
those who lived in a care home prior to admission had significantly shorter length of stay (mean LOS
20 days, p = 0.013). In those who survived a bleed, patients with advanced age (mean LOS 33 days
for patients aged ≥85 years, p = 0.006) had significantly longer LOS. In patients who died following
an ischemic event, the presence of lateralisation (mean LOS 12 days, p = 0.003) was associated with
increased length of stay. Amongst patients who died following a haemorrhagic TACS, the presence
of lateralisation (mean LOS 10 days, p = 0.014), advanced age (mean LOS 11 days for patients aged
≥85 years, p = 0.04) and modified Rankin scores 1 (mean LOS 15 days, p = 0.042), 2 (mean LOS 19 days,
p = 0.025) as compared with those who had a baseline score of 0 were associated with longer of lengths
of stay.
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Table 1. Total anterior circulation stroke patient cohort characteristics.
Total % Ischemic % Hemorrhagic %
Stroke Type
Ischaemic 2439 82.3 - -
Haemorrhage 526 17.7 - -
Mortality
Survived 1258 42.4 1060 43.5 198 37.6
Died 1707 57.6 1379 56.5 328 62.4
Age
<65 years 232 7.8 167 6.9 65 12.3
65–85 years 1717 57.9 1381 56.6 336 63.9
≥85 years 1016 34.3 891 36.5 125 23.8
Gender
Female 1719 58.0 1452 59.5 267 50.8
Male 1246 42.0 987 40.5 259 49.2
Lateralization
Yes 2693 90.8 2256 92.5 437 83.1
No 272 9.2 183 7.5 89 16.9
Residence
Care Home 456 15.4 399 16.3 57 10.8
Home Alone 988 33.3 829 34.0 159 30.2
Home
Family 1521 51.3 1211 49.7 310 59.0
Rankin Score
mRs 1 0 1477 58.7 1175 56.8 302 67.46
mRs 1 206 8.2 175 8.4 31 6.9
mRs 2 235 9.3 193 9.3 42 9.4
mRs 3 312 12.4 264 12.8 48 10.7
mRs 4 or 5 287 11.4 262 12.7 25 5.6
Comorbidity
AF 2 No 2479 83.6 1965 80.6 514 97.7
AF Yes 486 16.4 474 19.4 12 2.3
CHF 3 No 2675 90.2 2155 88.4 520 98.9
CHF Yes 290 9.8 284 11.6 6 1.1
CKD 4 No 2911 98.2 2385 97.8 526 100
CKD Yes 54 1.8 54 2.2 0 0
MI 5 No 2815 94.9 2312 94.8 503 95.6
MI Yes 150 5.1 127 5.2 23 4.4
DM 6 No 2877 97.0 2352 96.4 525 99.8
DM Yes 88 3.0 87 3.6 1 0.2
1 mRs = modified Rankin scale; 2 AF = atrial fibrillation; 3 CHF = congestive heart failure; 4 CKD = chronic kidney
disease; 5 MI = myocardial infarction; 6 DM = diabetes mellitus.
Table 2. Adjusted combined length of stay analysis with 95% confidence intervals of ischaemic and
haemorrhagic TACS.
Ischaemic TACS Haemorrhagic TACS
N Mean SD 95% CI p-Value N Mean SD 95% CI p-Value
Age
<65 years 167 19.7 23.5 65 13.8 17.9
65–84 years 1381 17.8 17.7 −5.87–2.08 0.350 336 15.1 17.4 −5.98–4.17 0.727
≥85 years 891 16.9 18.1 −6.64–1.92 0.280 125 16.2 18.9 −5.42–6.88 0.816
Gender
Female 1452 17.7 18.3 267 15.2 17.6
Male 987 17.6 18.3 −2.34–1.15 0.506 259 15.1 18.1 −2.07–4.81 0.436
Lateralisation
No 183 15.2 21.1 89 9.7 18.3
Yes 2256 17.8 18 −2.07–5.01 0.415 437 16.3 17.5 2.32–11.9 0.004
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Table 2. Cont.
Ischaemic TACS Haemorrhagic TACS
N Mean SD 95% CI p-Value N Mean SD 95% CI p-Value
Residence
Home Alone 829 18.5 20 159 16.2 19.2
Home
Family 1211 17.9 18.1 −3.05–0.88 0.280 310 15 17.2 −5.67–2.81 0.509
Care home 399 15.1 14.5 −4.77–0.74 0.152 57 13.4 17.3 −9.74–4.03 0.416
Rankin Score
mRs 0 1175 19.1 19.4 302 15 18.6
mRs 1 175 18.8 20.3 −3.63–3.01 0.856 31 20 19.4 −1.72–13.7 0.128
mRs 2 193 18.4 20.4 −3.63–2.65 0.760 42 16.7 17.4 −3.74–7.69 0.498
mRs 3 264 16 15.3 −5.12–−0.5 0.014 48 16.8 17.5 −3.90–6.86 0.590
mRs 4 or 5 262 14.9 15.3 −6.15–−0.6 0.015 25 12.4 13.3 −7.37–5.41 0.763
Comorbidity
AF No 1965 17.5 18 514 15.3 17.9
AF Yes 474 18.2 19.4 −1.55–3.14 0.506 12 10.2 12.9 −9.62–9.56 0.996
CHF No 2155 17.5 17.7 520 15.3 17.9
CHF Yes 284 18.7 22.5 −1.53–4.39 0.345 6 5.8 5.6 −18.4–−1.09 0.027
CKD No 2385 17.6 18.3 526 15.2 17.8
CKD Yes 54 17 17.1 −4.73–5.56 0.875 0 - -
MI No 2312 17.5 17.9 503 15 17.4
MI Yes 127 19.2 24.3 −3.78–6.08 0.647 23 18 25.4 −7.29–14.5 0.518
DM No 2352 17.7 18.4 525 15.2 17.8
DM Yes 87 16.4 15.4 −2.49–5.17 0.492 1 1 -
Table 3. Adjusted length of stay analysis with 95% confidence intervals of ischaemic and haemorrhagic
TACS in patients who were alive at discharge.
Ischaemic TACS Haemorrhagic TACS
N Mean SD 95% CI p-Value N Mean SD 95% CI p-Value
Age
<65 years 119 25.1 25.5 40 19.6 20.4
65–84 years 669 24.4 19.7 −6.71–3.64 0.561 129 24.1 21.7 −5.37–9.76 0.569
≥85 years 272 25.2 20.7 −6.75–5.37 0.823 29 33.3 25.1 5.15–30.5 0.006
Gender
Female 612 24.9 21 102 25.4 22.7
Male 448 24.3 20.2 −3.41–2.36 0.720 96 23.6 21.8 −5.21–8.87 0.611
Lateralisation
No 59 29.3 29.1 23 19.9 30.8
Yes 1001 24.4 20.1 −16.2–0.84 0.077 175 25.2 20.9 −7.79–22.2 0.346
Residence
Home Alone 346 26.6 23.3 66 26.6 24.8
Home
Family 591 24.4 19.8 −6.08–0.82 0.135 114 23.4 20.1 −11.6–4.50 0.387
Care home 123 20.4 15.8 −12.2–−1.43 0.013 18 24.5 25.6 −20.4–10.1 0.506
Rankin Score
mRs 0 625 25 21.7 125 24.4 23.3
mRs 1 73 25.3 24.5 −5.70–5.99 0.962 10 30.1 22.2 −7.54–22.2 0.334
mRs 2 79 24.1 16.1 −5.10–3.30 0.674 17 17 14.8 −18.8–2.88 0.150
mRs 3 90 24.6 18.2 −4.59–4.43 0.973 14 30.6 24.7 −10.4–17.6 0.612
mRs 4 or 5 79 21.4 17.8 −7.13–4.89 0.715 6 22.3 21.8 −18.5–9.01 0.499
Comorbidity
AF No 902 24.3 20.5 196 24.6 22.3
AF Yes 158 27 21.5 −3.52–4.88 0.750 2 17.5 17.7
CHF No 979 24.1 20.2 197 24.6 22.3
CHF Yes 81 31.8 25 −0.11–11.1 0.055 1 16 -
CKD No 1043 24.6 20.7 198 24.6 22.2
CKD Yes 17 32.1 21.5 −1.85–17.2 0.114 0 NA NA
MI No 1017 24.3 20.5 193 24 21.4
MI Yes 43 32.4 22.6 −0.88–14.3 0.083 5 45.2 43.3
DM No 1033 24.8 20.7 198 24.6 22.2
DM Yes 27 21 19.1 −10.6–7.29 0.720 0 NA NA
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Table 4. Adjusted length of stay analysis with 95% confidence intervals of ischaemic and haemorrhagic
TACS in patients who died during admission.
Ischaemic TACS Haemorrhagic TACS
N Mean SD 95% CI p-Value N Mean SD 95% CI p-Value
Age
<65 years 48 6.2 7.4 25 4.5 6.2
65–84 years 712 11.7 12.8 2.82–8.59 0.000 207 9.4 10.8 −0.27–7.60 0.068
≥85 years 619 13.3 15.4 3.79–10.6 0.000 96 11 12.8 0.23–10.3 0.040
Gender
Female 840 12.4 13.8 165 8.9 8.9
Male 539 12 14.3 −1.56–2.11 0.768 163 10.1 13.2 −0.32–5.20 0.084
Lateralisation
No 124 8.5 10.8 66 6.2 9.2
Yes 1255 12.6 14.2 1.28–6.18 0.003 262 10.3 11.6 0.80–6.93 0.014
Residence
Home Alone 483 12.7 14.6 93 8.8 8.2
Home
Family 620 11.6 13.8 −2.69–1.26 0.477 196 10 12.9 −1.60–4.67 0.337
Care home 254 13 12.8 −2.26–3.16 0.744 39 8.3 8 −7.65–2.36 0.300
Rankin Score
mRs 0 550 12.3 13.5 177 8.4 10.1
mRs 1 102 14.2 15.2 −2.02–4.60 0.445 21 15.1 16.4 0.28–14.5 0.042
mRs 2 114 14.5 22.1 −2.66–5.34 0.512 25 16.5 19.3 1.05–15.7 0.025
mRs 3 174 11.5 11.3 −4.01–0.48 0.123 34 11 8.9 −0.55–6.83 0.095
mRs 4 or 5 183 12.1 13.2 −4.39–1.07 0.233 19 9.3 7.9 −1.68–7.65 0.209
Comorbidity
AF No 1063 11.7 13.1 318 9.5 11.2
AF Yes 316 13.7 16.7 −1.19–3.87 0.298 10 8.7 12.5 −8.71–13.1 0.693
CHF No 1176 12 12.9 323 9.6 11.3
CHF Yes 203 13.5 19.1 −1.61–4.60 0.344 5 3.8 2.8
CKD No 1342 12.3 14.1 328 9.5 11.2
CKD Yes 37 10.1 8.3 −7.08–0.12 0.058 0 NA NA
MI No 1295 12.2 13.3 310 9.4 11.3
MI Yes 84 12.4 22.4 −6.24–5.32 0.877 18 10.4 10.7 −4.80–5.78 0.855
DM No 1319 12.1 14 327 9.5 11.2
DM Yes 60 14.3 13.1 −1.55–6.27 0.237 1 1 NA
4. Discussion
We have identified several factors associated with both shorter and longer length of stay in
patients who presented with a total anterior circulation stroke. Predictive criteria such as the PLOS
score [11] includes variables such as stroke severity assessed by NIHSS score, stroke type, decreased
consciousness on admission, congestive heart failure and atrial fibrillation to predict length of stay but
its generalizability has been questioned [16] and it was not specific to TACS patients, who often suffer
the greatest burden of post-stroke disability and the most prolonged length of stay.
To date, much of the literature has focussed on stroke severity, rather than on specific clinical
features of neurological deficit, as a predictor of length of stay, with increasing stroke severity scores
associated with longer inpatient admission [17,18]. However, lateralization forms part of the criteria
of assessment in several validated stroke severity scoring tools, including the NIHSS score and the
Canadian Neurological Score [19–21]. Early functional improvement in paretic limbs following anterior
circulation stroke has been shown to predict greater recovery while those limbs lacking voluntary
movement in the few days following the occurrence of stroke were associated with poorer outcome [22].
Our study had similar findings with lateralisation increasing length of stay in those patients who
died of ischaemic or haemorrhagic TACS and increasing overall inpatient stay in haemorrhagic TACS,
with such a deficit likely reflecting increased severity of stroke and vulnerability to complications
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of immobility, including infection, venous thrombo-embolism and pressure sores. Severity scoring
tools were not included in the analysis for the current study. Rather, the inclusion of a broader binary
measure of impairment (lateralization or not) instead of the specific grade of limb weakness may have
decreased the potential for inter-rater variability in the assessment of neurological deficit.
Advancing age has previously been shown to be predictive of longer length of stay [23] and poor
outcomes in stroke, including change in residence to nursing home care reflecting an individual’s
increased dependence and care needs if they survived the stroke [24]. In clinical practice the delayed
availability of such care often represents a rate-limiting aspect to speed of discharge in health care
systems such as in the National Health Service in the UK. The current finding of advanced age being
associated with increased length of stay is supported by a recently validated length of stay prediction
tool [10] with a similar cohort mean age being observed in both studies, and differs to earlier studies
which had younger cohorts that did not show an association between age and length of stay [18].
An ever-increasing elderly population is a prominent factor in contemporary medical practice that
places further demands on health services. Recognising the impact age has on length of stay has
therefore important resource allocation implications, emphasising the requirement for early review of
patient’s pre & post-morbid functional status, detailed collateral history at the point of admission and a
multi-disciplinary (including social worker) review given the higher likelihood that an elderly patient
will need greater resource (i.e., care or change in residency to nursing home) utilisation. The earlier
thus work could be done for these elderly patients the more efficiently their LOS could be influenced.
Equally, stroke services should take into account patient demographics such as age, not just the number
of population they serve, so stroke unit beds are able to cope with increasing ageing populations.
Congestive heart failure (CHF) has previously been reported to prolong length of stay following
stroke [11,25] and transient ischaemic attack [26], forming one of the criteria in the aforementioned
PLOS score. In keeping with prolonged length of stay CHF has been reported as a predictor of
increased cost following stroke [25,27]. It could be expected that increased comorbidity prior to TACS
would contribute to more prolonged recovery, placing further limitation on rehabilitation effort and
exacerbating vulnerability to complications that accompanies an acute insult such as a TACS. However,
in the current study patients with a haemorrhagic stroke and a history of CHF had approximately
only one third of the mean length of stay of those patients who were without pre-morbid cardiac
impairment. CHF has also been associated with increased mortality following stroke [28] and this
may also account for the decreased length of stay in the haemorrhagic TACS cohort in the current
study, where patients with poor physiological reserve succumbed having suffered the most severe
form cerebrovascular injury. It would be of interest to observe similar findings in future studies
to establish this link further. Cardiac failure and cerebrovascular disease share similar risk factors,
such as hypertension, atrial fibrillation and hypercholesterolaemia (as a contributor to ischaemic
cardiomyopathy). The association of poor outcomes between heart failure and stroke underlines the
importance of risk factor modification and achieving primary and secondary prevention targets.
Higher pre-stroke modified Rankin scores have previously been reported to influence length of
stay and mortality [29]. In the primary analysis a reduced length of stay was seen in patients with
higher disability (mRs group 3 and 4 or 5) who suffered an ischaemic TACS. This may in part be
due to higher inpatient mortality rates being seen in the study’s cohort who had a pre-stroke mRs
of 3 (p = 0.003) and 4 (p = 0.014) and an associated relatively shorter LOS. Equally, among those who
survived to discharge, patients who had higher degrees of disability may have been less likely to
benefit from intensive, acute stroke rehabilitation prompting more timely discharge back to their
pre-stroke residence with appropriate care arrangements that were already catering for their needs.
This is also reflected by the fact patients admitted from care settings had shorter LOS. Amongst those
patients who died, minimal to mild pre-morbid disability predicted increased length of stay following a
haemorrhagic event. This longer length of stay likely reflects that these patients were now significantly
unwell following their event but may have had some degree of physiological reserve that enabled
them to survive for a period of time before succumbing to their acute illness. Equally, discharge
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planning may have been a factor with these patients becoming more care dependent following such
an event and their prolonged stay reflecting the time requirement to arrange new, suitable discharge
destinations such as a high intensity nursing home or hospice.
The main study limitation is that it is based on one centre’s experience in the UK NHS setting and
patient cohort where stroke management resources, delivery and patient characteristics may differ
in other places and settings. Also, the analysis was conducted retrospectively. However, the data
were collected prospectively, except for co-morbidities, which were documented prospectively in the
medical notes and identified at a later stage using electronic records. This prospective data collection of
consecutive admissions and the lack of exclusion criteria to the register limit the possibility of selection
bias and reflect a real world picture.
5. Conclusions
In summary, the identification of contributors to length of stay would aid the development of
useful prediction criteria in future studies. This study with a large cohort of patients contributes
valuable information to predicting which patients will have an extended or likely shorter inpatient stay
following a TACS. This information can potentially be used for planning of services and projections of
future health care costs in stroke populations with knowledge about the incidence of TACS within
local stroke patient populations. Further studies in multiple settings would be beneficial to validate
predictive criteria for TACS length of stay given its wide-ranging impact on healthcare providers
and patients.
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